John Inman, MD
Obstetrics & Gynecology · Albany, GANPI 1912991241
Payments from drug & device makers
Across 156 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$457
- Astellas Pharma US Inc$449
- Amgen$394
- AbbVie$381
- Pfizer$85
- Lilly USA, LLC$81
- plus $955 from 32 others
What the payments were for
- Food & beverage$2,64794%
- Education$1556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $457 |
| Astellas Pharma US Inc | 22 | $449 |
| Amgen | 23 | $394 |
| AbbVie(2 entities) | 21 | $381 |
| Pfizer | 5 | $85 |
| Lilly USA, LLC | 5 | $81 |
| Ultragenyx Pharmaceutical Inc. | 3 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Scilex Pharmaceuticals Inc. | 3 | $68 |
| Dexcom, Inc. | 3 | $59 |
| Abbott | 3 | $59 |
| Hologic Sales And Service, LLC | 3 | $54 |
| Exact Sciences | 3 | $50 |
| Corium, LLC | 2 | $39 |
| Bayer | 2 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Kyowa Kirin, Inc. | 2 | $37 |
| Rhythm Pharmaceuticals, Inc. | 1 | $31 |
| Medtronic | 2 | $30 |
| Radius Health, Inc. | 2 | $28 |
| Avion Pharmaceuticals | 1 | $26 |
| Cepheid | 1 | $22 |
| Baxter Healthcare | 1 | $20 |
| Millicent US Inc | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Myovant Sciences Inc. | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Coopersurgical, Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $15 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Irhythm Technologies, Inc. | 1 | $13 |
| Valeritas, Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 2 | $9 |
How this compares
$2,802 in reported general payments places this provider in the 75th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 68 | $53,560 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 21 | $50,586 |
| MyrbetriqMirabegron | 38 | $33,670 |
| PremproEstrogen,con/M-Progest Acet | 49 | $12,256 |
| Estradiol | 364 | $12,116 |
| PremarinEstrogens, Conjugated | 34 | $11,300 |
| LinzessLinaclotide | 18 | $9,009 |
| Risedronate Sodium | 34 | $3,274 |
| PremphaseEstrogen,con/M-Progest Acet | 13 | $3,091 |
| ImvexxyEstradiol | 11 | $2,121 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 24 | $2,019 |
| VagifemEstradiol | 12 | $1,659 |
| Vivelle-DotEstradiol | 11 | $1,542 |
| ValacyclovirValacyclovir Hcl | 42 | $1,534 |
| Clobetasol Propionate | 35 | $1,047 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $15 | $53,56068 claims |
| AmgenEvenity (2 Syringes) | $394 | $50,58621 claims |
| Astellas Pharma US IncMyrbetriq | $449 | $33,67038 claims |
| PfizerPrempro, Premarin | $85 | $23,55683 claims |
| AbbVieLinzess | $381 | $9,00918 claims |
| Almatica Pharma LLCSertraline Hcl | $16 | $35123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Albany
- Paul SmurdaAlbany$29K
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- David MontaldiMarietta$1.1M
- Winifred SoufiAtlanta$889K
- Richard ZaneAlpharetta$638K
- Edmund KimLawrenceville$628K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.